FindTrial
Sign In

The mechanism of cardiovascular disease in patients with hypertension and hyperuricemia

The mechanism of cardiovascular disease in patients with hypertension and hyperuricemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070684
Enrollment
Unknown
Registered
2023-04-20
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension hyperuricemia cardiovascular disease

Interventions

Hypertension:None
Hypertension hyperuricemia:none
Hypertension CVD:none
Hypertension with hyperuricemia and coronary heart disease:None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Diagnosed as essential hypertension.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension; 2. Congenital heart disease, rheumatic heart disease, cardiomyopathy, malignant arrhythmia; 3. Pregnant women; 4. Autoimmune diseases; 5. Severe liver insufficiency (ALT and AST>3 times the upper normal limit); 6. Severe renal insufficiency (eGFR < 30 m/min * 1.73 m2); 7. Chronic consumptive diseases (serious infection, malignant tumor); 8. Severe gastrointestinal diseases; 9. Antibiotics, probiotics and uric acid lowering drugs used within 8 weeks.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;Blood metabolite;—

Countries

China

Contacts

Public ContactLiu Yuqi

PLA General Hospital

ametuofo980869@163.com+86 150 1146 1841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026